Form 8-K - Current report:
SEC Accession No. 0001962918-25-000014
Filing Date
2025-01-31
Accepted
2025-01-31 16:26:06
Documents
13
Period of Report
2025-01-31
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K slrn-20250131.htm   iXBRL 8-K 26337
  Complete submission text file 0001962918-25-000014.txt   152543

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT slrn-20250131.xsd EX-101.SCH 1773
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT slrn-20250131_lab.xml EX-101.LAB 22530
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT slrn-20250131_pre.xml EX-101.PRE 13037
15 EXTRACTED XBRL INSTANCE DOCUMENT slrn-20250131_htm.xml XML 2815
Mailing Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301 805-456-4393
ACELYRIN, Inc. (Filer) CIK: 0001962918 (see all company filings)

EIN.: 852406735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41696 | Film No.: 25578687
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)